5AM Partners VI, LLC - Aug 24, 2023 Form 4 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role
10%+ Owner
Signature
5AM Partners VI, LLC, By /s/ Kush Parmar, Managing Member
Stock symbol
ELVN
Transactions as of
Aug 24, 2023
Transactions value $
-$7,040,000
Form type
4
Date filed
8/28/2023, 04:20 PM
Previous filing
Feb 28, 2023
Next filing
Sep 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELVN Common Stock Sale -$5.87M -367K -7.59% $16.00 4.47M Aug 24, 2023 By 5AM Ventures VI, L.P. F1, F2
transaction ELVN Common Stock Sale -$1.17M -72.9K -7.59% $16.00 888K Aug 24, 2023 By 5AM Opportunities I, L.P. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI, Dr. Parmar and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein.
F3 The shares are directly held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Dr. Parmar and Mr. Schwab disclaims beneficial ownership of such shares, except to the extent of its or his respective pecuniary interest therein.